A: You can complete all the required tests quickly on-site at clinique ovo and the fees will be reimbursed by most insurance companies. You can also complete your examinations in hospitals and at CLSC, and these will be covered by the RAMQ insurance card in Quebec.
A: You can collect the sample at home in a sterile container and take it directly to our laboratory within one hour of production. The specimen should be kept at body temperature (close to the body).
A: You will need a recent pre-conception work-up (exceptionally, we can proceed without the work-up in cases of fertility preservation; units will then be quarantined pending the results) and a physician’s prescription indicating “freezing of sperm.” For more information, contact ovo cryo at 514 798-2000, ext. 203.
A: harmony is a non-invasive prenatal test performed with a simple blood sample that can detect trisomy 13, 18 and 21, sex chromosome abnormalities and fetal sex.
harmony allows for a significant reduction of the need for invasive procedures such as amniocentesis and chorionic villus biopsy, which can cause miscarriage in about 0.5 to 1% of cases.
In case of a positive harmony test result (high risk for trisomy), an invasive diagnostic technique will be suggested to confirm this result.
When: From 10 weeks
Time frame: 5 to 11 working days
Inclusions: Fetal sex + Sex chromosome anomalies
Advantage: Fetal DNA test approved by Health Canada
Detection rate for trisomy 21: over 99.9%
A: optimo is a screening test done during the first trimester of pregnancy, between 11 weeks + 4 days and 13 weeks + 6 days. It involves:
The ultrasound aims to verify if the fetus is growing and thriving and has no malformations. It also measures nuchal translucency.
The blood test screens for serum markers, which are substances present in the mother’s blood that are produced by the developing placenta.
These tests present no risks for the pregnancy carrier or the fetus.
A: The Harmony test is done mainly to screen for trisomies 21, 18 and 13.
fA: You will receive your result within five to eleven business days. If your risk is low, you will be informed by email. A copy of the result will also be sent to your physician.
A: The detection rate for trisomy 21 is 99.9%.
A: Your participation in a research study is completely voluntary. You are free to refuse and withdraw your participation at any time. Your decision will have no consequence on the quality of care, treatment or your relationship with your treating physician at clinique ovo.
A: Each participant is closely monitored by a team of experienced health professionals. During a visit with the research nurse, the possible side effects of the study will be mentioned. Furthermore, the potential side effects are written in the informed consent form that will be given to you.
A: Any medication can have a risk of side effects. When you meet with the research nurse, the potential side effects will be mentioned. Furthermore, the list of possible side effects can be found in the copy of the consent form that will be given to you.